Psoriatic Arthritis Clinical Trial
What is Psoriatic Arthritis?
This disease, associated with psoriasis, causes chronic pain, stiffness and swelling in the joints. Early diagnosis is important.
About the Study
A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy
Compensation for Time and Travel
Study participants who satisfy applicable requirements – All study related visits, care, tests, and medication will be provided to participants at no cost. Reimbursement for time and travel may be provided. Please contact us for more information as it varies by each study.
Who is Eligible to Participate?
If you are 18 years of age or older and diagnosed with Psoriatic Arthritis
This clinical research study will evaluate the effectiveness of an investigational drug for the treatment of Psoriatic Arthritis
This information is not inclusive of the required eligibility criteria.
Please Call or Text our office at 407-574-5650 to learn more and book a no cost assessment with our Research Physicians.